Varga C, Pocsai Z, Kertai P
Department of Hygiene and Epidemiology, University Medical School, Debrecen, Hungary.
Mutagenesis. 1995 Jan;10(1):43-5. doi: 10.1093/mutage/10.1.43.
Urine and serum samples of rats bearing three different experimental tumours (hepatocellular carcinoma, myelomonocytic leukemia and mesoblastic nephroma) were investigated for mutagenicity with the Ames Salmonella test. Enhancement of mutagenic activity in TA98 and TA100 was observed only in the case of urine samples obtained from animals bearing nephromas. Mutagenicity increased with increasing time after implantation of tumours. There was no coincidence between urinary and serum mutagenicity under the experimental conditions employed. Further studies are needed to determine the origins, and chemical and genotoxic characteristics of urinary mutagens. In addition, the question as to whether any mutagenic substances can be detected in fractions of plasma/serum should also be experimentally addressed.
对患有三种不同实验性肿瘤(肝细胞癌、骨髓单核细胞白血病和中胚层肾瘤)的大鼠的尿液和血清样本进行了艾姆斯沙门氏菌试验以检测其致突变性。仅在从患有肾瘤的动物获得的尿液样本中观察到TA98和TA100中致突变活性增强。致突变性随肿瘤植入后时间的增加而增加。在所采用的实验条件下,尿液和血清的致突变性之间没有相关性。需要进一步研究以确定尿液诱变剂的来源、化学和遗传毒性特征。此外,关于血浆/血清组分中是否能检测到任何诱变物质的问题也应通过实验解决。